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University of Denver Undergraduate Research Journal
Faculty Spotlight — Dr. Corinne Lengsfeld
Interviewed by Bailey McGinley1 and Owen McKessy1
1DUURJ Staff Editors, University of Denver
1 DO YOU MIND TELLING US ABOUT
YOURSELF, SUCH AS WHERE YOU WENT
TO SCHOOL, HOW YOU BECAME
INTERESTED IN YOUR MAJOR RESEARCH
AREAS, AND HOW YOU FOUND YOUR WAY
TO DU?
I’m a mechanical engineer by training. I got my degrees
at the University of California, Irvine and of all things,
I majored in rocket science. I worked on my postdoc at
Boulder for two years, in the pharmaceutical industry
in their Chemical and Biochemical Engineering Pro-
gram, and re-trained myself from rocket engines into
pharmaceutics. There’s actually a lot of commonalities
between the two fields. At the time, I was one of three
mechanical engineers that were working in the pharma-
ceutical industry, so I was sort of crazy weird. I joined
DU in 1999, as a professor in mechanical engineering,
and had a blast with the students. We did all sorts of
incredible things, like working for the Air Force and
working for pharmaceutical companies. We were well
funded and we had a great time. I really love teaching
and the whole teacher scholar model here at DU.
About eight years ago, the person that was leading
research at the University stepped down and accepted
a dean position at another university, and she called
me and suggested that I take over her position. I was
hesitant at the time, because I had a big research group,
and I was enjoying what I was doing. On the other
hand, I also knew that DU was transforming from a
school with a teaching intensive faculty to a faculty that
balances their research with their teaching, and I was
super interested in forging this university forward in
the research sphere. It was important to me to do this
in such a way that the love I had with the students
would propagate forward and not be diminished by the
research. So that’s how I ended up heading research.
2 HOW HAS WORKING WITH
INVESTIGATORS FROM DIFFERENT
DISCIPLINES (YOU’RE A MECHANICAL
ENGINEER BY TRADE, DR. SARAH
WATAMURA A PROFESSOR OF
PSYCHOLOGY, AND DR. PHIL DANIELSON
A MOLECULAR BIOLOGIST) HELPED IN
THE SUCCESS OF THE SPIT LAB?
Being interim provost at the start of the pandemic, I was
pretty much all about COVID for four or five months.
I decided to roll back to my research position, and it
actually worked out really well because I had asked
Sarah Watamura to help me with COVID while I was
still Interim Provost and then when I rolled back to re-
search, I helped her continue to run COVID. So, the two
people that really had been running the university’s re-
sponse to COVID the whole time, ended up continuing
together.
Sarah was a salivary scientist, she was collecting spit
in kids for years and measuring their stress level. She
suggested we should do COVID saliva testing and as
an engineer, I understood pharmaceuticals, diagnostics,
and supply chain. Then, we got Phil Danielson to join
us. He’s a forensic scientist, and if you’re going to look
for a little elusive molecule in saliva, who better than
somebody that looks for all sorts of things in bodily flu-
ids from crime scenes. The three of us just got together
and dreamed up what is now the Spit Lab, which is
incredible. A small team has been innovating all the
way through and using every ounce of experience we
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have but really just applying it in completely different
spaces.
I knew we had to build all our own software, so
I called over to computer science and spoke to Matt
Rutherford. I said, “Do you know anybody that would
help us?” He was like “Well, what do you mean?” I said,
“I pretty much think we’re gonna not sleep much. And
we’re gonna have to work really hard. And I don’t even
know if it’s gonna work. But I think we’ll save the day
if we can do it.” He’s all, “I’m all in, it sounds perfect.”
Then, Nancy (Lorenzon) was hanging out close to us
one day. We were collecting saliva at the pod, and she
came over and she said, “I want to help.”
All of the aerosol calculations were done with Dr.
Alex Hoffman in chemistry. That’s how we figured out
how to set up the rooms and which rooms needed extra
filtration units.
Then, I spoke with Keith Miller, he’s an environmen-
tal water sampler. I said, “So wastewater is kind of envi-
ronmental, do you want to do this with me?” I think by
September 9th we were starting to pull samples out of
the sewers. It’s been a lot of fun to work with so many
different faculties.
3 AS PRINCIPAL INVESTIGATOR FOR DU’S
SPIT LAB, WHAT ARE YOUR MAIN
RESPONSIBILITIES?
There’s the research side and the public health side,
so let’s start on the public health side. I’m ultimately
responsible for the entire operation of the Spit Lab. This
includes making sure Phil Danielson and his team have
all the equipment they need and helping them to solve
any problems or issues that they come up with. I help
Nancy Lorenzon to oversee the interns and make sure
they’re trained and that we are living up to our CLIA lab
certification. A major part of my role as PI is entering the
results of tests into the system once they are sent to me
from the lab, as well as clearing and posting the results
in the medical records. In other words, I’m the final
authority when it comes to all of the data collected by
the lab. I might not do the finger work, but I will notify
contact tracing of who’s received a positive test and I’ll
have verified that the data is accurate. I also manage
any questions that students or the parents may have
about saliva as a new detection technique. Methods for
saliva testing are wildly varying across the country, and
our lab holds itself to the highest standard possible, so
it’s really easy to defend our results.
On the research side, I really am the only person
that sees all the informed consents. For this reason, we
haven’t started any research studies. We’ve only col-
lected public health data, but we have one of the best
databases, in my opinion, that is able to tell us who has
been positive, where they were living, and where they
might have gone while carrying the virus. All of the
people in the database have consented to be a part of
the study, and as the PI, I know who’s consented and
what I’m allowed to do with the data. I’m ultimately re-
sponsible for assuring that people’s privacy is protected.
This means that when we move into the research phase
and other scientists get access to the database, they will
see nothing but numbers and they will never see the
names associated with the data. At this point, we have
used all of our data for public health initiatives to help
inform our response, but we haven’t begun pursuing
any research yet. Before any research can start, you
need to be sure there are systems in place that protect
the identity of everyone that participated in the study.
It’s not like you can just begin research right away, and
as a responsible PI, you need to make sure that all of the
data is presented correctly, and there will be no room
for mistakes.
4 AT THE MOMENT, SALIVA TESTING IS NOT
FDA APPROVED. HOW IS THE CURRENT
RESEARCH YOU ARE DOING HELPING
YOU AND YOUR TEAM WORK TOWARDS
GETTING THAT FDA APPROVAL?
We submitted our Emergency Use Authorization ap-
plication a few months ago, maybe in January, but we
submitted at a time when the federal government an-
nounced they were not going to issue any EUAs to
universities. We are one of 32 universities who have
pending EUA applications. We have been in constant
contact with the FDA, and we know that our application
is under review because they keep asking Dr. Danielson
questions.
We also know that of the 32 universities that have
submitted applications, we’re almost the only one that
uses the extraction technique. You can either process
saliva as is and send it into the PCR, or you can take an
extra more expensive step to extract off the virus and
concentrate it and send it into the PCR. We decided to
use the extraction technique because it creates a higher
standard of performance and accuracy. We are very
confident that we will be one of the first university labs
to be approved because essentially we are replicating
the techniques used in nasal swab testing and applying
them to saliva. It’s just they don’t want to approve any
universities, yet, for whatever administrative reasons.
So we’ll wait, and then we’ll get it.
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5 TESTING FOR COVID-19 HAS BEEN MADE
POSSIBLE THROUGH UNDERGRADUATE
INTERNS AND VOLUNTEERS, CAN YOU
GO INTO A BIT MORE DETAIL ON HOW
UNDERGRADUATE STUDENTS HAVE BEEN
IMPORTANT IN THE UNIVERSITY’S
RESPONSE TO THE VIRUS?
I’m just going to kind of rattle off some of the jobs, we
have two undergraduates run all the installation of the
wastewater twice a week. Dr. Miller pulls the sample
with a plumber then two students actually do all the
installations on Sundays and Wednesdays. We also have
some students that work inside the Spit Lab doing the
antigen testing, which people often forget that the Spit
Lab actually does do nasal swab testing, but we do it
for antigen testing in symptomatic cases.
Then, we have all the spit interns that are wonderful,
and they run the collection sites. We just promoted a
few of them to be paid leads and actually take on more
organizational responsibility. Then we have a number
of the interns who are taking leadership roles out at the
vaccination clinics, who are helping manage and orga-
nize the operations of different elements of the vaccine
clinics. We have two interns that are pretty amazing,
John and Maya, who have taken on pretty large respon-
sibilities at the vaccination clinics.
We’ve had students also help in a number of other
ways. We had a vaccine call clinic, and we were like
the only place in the state you could call and talk to a
human. We had a 13 phone phone-bank and the stu-
dents could run it from their computer. Undergraduate
and graduate students helped keep that phone bank
alive for almost three months, taking appointments and
registering people.
Then we have a bunch of students from Professional
Psychology, who are part of our student ambassador
program, that are using their psychology training to
reach out and connect with students in quarantine
and isolation. They just connect with them, make sure
they’re okay. Get them resources, if they’re not.
We’ve had a bunch of students that would run
around delivering from time to time, picking up things
people needed. In the beginning of fall, our isolation
dorms and our quarantine dorm rooms didn’t have all
the supplies, and there were students that would go out
shopping and they would bring everything back to the
university so we could go out and deploy it.
Students have been involved in ways that I don’t
think have been recognized, but they have been in-
volved from the very beginning and are really sup-
porting the COVID response team. We’ve been terri-
bly grateful that they’ve been there, and they’ve never
asked for anything in return. They’ve been so great and
just really dependable.
6 FROM THE OUTSIDE LOOKING IN, IT
LOOKS LIKE THE SPIT LAB HAS
CONSTANTLY BEEN EVOLVING AND
IMPROVING. WHAT HAS BEEN THE
BIGGEST CHALLENGE YOU AND YOUR
TEAM HAVE FACED, AND HOW DID YOU
OVERCOME IT?
So, I gotta say, there’s two most difficult moments. Once
we got the lab up and running, it was about December
1st. We’d run for two weeks, and had figured out what
we wanted to do and wanted to start testing. And then
we ran out of supplies, like we literally ran out of sup-
plies. We had to ask National Jewish and the CDPHE to
borrow some things to keep us in business, but on De-
cember 4th I had to close the lab. I didn’t fire anybody or
anything like that, but I said, you’re not allowed to run
a single sample because I needed us to open on January
4th, when the first people moved into the dorm. I only
had supplies to go from January 4th to January 10th,
and so on December 4th, we closed. It was a very diffi-
cult day for Phil, Sarah, and I to admit that we hadn’t
kept track of the supply chain enough, that we hadn’t
understood what it was going to be. And then what was
worse is that we had to jump into a supply chain mar-
ket that, you know, we’re a medium sized school, like,
I couldn’t buy enough to become the powerhouse so
we ended up getting these two people in purchasing to
help us. These two staff members who just volunteered
extra time and when everybody else left on December
21st, we worked every day trying to find plastics all
over the world. Our goal was to get us to January 15th.
And then from January 15th, could we get to January
30th. It wasn’t until about January 30th that we had
enough supplies to get us through winter quarter. I
mean, we sweated it every day. That was really a major
situation, but now that we’re at about 1200 samples a
day, I don’t think anybody on this campus has had to
manage a supply chain like that, with so many complex
scientific items at that type of volume. That has been a
serious challenge for us, just yesterday I was down in
the warehouse myself counting pipette tips and bring-
ing them to the lab because we thought we might be
low and, nope, we had them. But you know, you’ve got
to always keep on top of that.
The other really horrible one was when all of us went
to go get vaccinated, everyone that was in the lab or
those of us that were pulling wastewater samples be-
cause we were in contact with the virus all the time. We
went to get vaccinated on a Wednesday, and then the
lab called me Friday morning and said we got a posi-
tive test in the lab. That meant that everybody would
be quarantined, and we’d have to shut down the lab.
So there we were, out there in the middle of night mea-
suring the distance between lab spaces and finding a
six foot distance or not. Can you imagine, it’s 12:30 at
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night and you’re out there with a tape measurer trying
to figure out if everybody was safely distanced. Many
of the interns will remember the very next Monday at
a group meeting I said everybody has to be six feet
apart, I don’t care if you’re friends, I don’t care if you’re
roommates, but the lab they quarantined. It was a really
bizarre sort of surreal 10 days in which three people
had to do the work of what used to be five people. It
was a strange, surreal sort of problem to live through.
It was great because the virus didn’t spread, and there
were no connected cases, we were literally six feet apart
wearing masks and it all worked. But we were really
worried that it was going to be the whole lab at some
point and that we didn’t get vaccinated early enough.
So that was another real challenge to overcome, balanc-
ing the needs of the campus with what each of those
individuals needed for their own personal well being.
It was just an incredibly difficult time, those early days
in January. For us, you never knew if we were going
to be successful or if it was going to sort of fall apart.
Every night was sort of a watershed night.
7 WHAT ARE THE NEXT STEPS FOR YOU
AND YOUR RESEARCH TEAM?
I think that from a public health point of view, what
we really are interested in is how many people who are
vaccinated have breakthrough infections? How many
who have already had COVID, get COVID Again? Is it
the variant? Is there a preference of the variants? We’re
really interested in that because that tells us what we
need to do for the fall. In the wastewater, picking up the
variant has been tough. So, Dr. Miller and Dr. Danielson
have teamed together and really came up with some in-
teresting ways to improve our wastewater monitoring.
We used to do that all third-party, but now we do it all
in house at the university to save money, but also to up
our game a little bit.
I think the variants are so interesting, right? Like, I
watched the variant come to campus. I remember the
night we got the first variant case. And I remember Phil
calling in a panic. Actually, we were on the intern call,
so we finished up our meeting, and I headed down to
the lab and we have two variants that might appear in
there. We load the first one into the robot that processes
the samples and all the equipment breaks, and it breaks
in dramatic fashion all in the same night. It throws
all the PCR plates against the wall, so it ruins all the
samples, and then leaks all over the floor. That was a
hard night, because none of us knew what the variant
meant. It was in the dorms and everybody said it was
so infectious and spreading. It was a difficult night. We
bought dinner for all the techs because it was a 2:00 AM
kind of night.
That night actually determined how we were going to
quantify the variant, how we were going to definitively
say, that’s the variant and that’s not. That science wasn’t
out there, Phil and I were building that science. We then
were writing a small research paper and submitting it to
Sarah as the peer reviewer, in sort of a mini peer review
cycle. So, it was really intense, but we just leaned on
our old research methods to do it once again. And then
over time, we saw this sort of sweep of variant shift that
is incredible to observe. Because we are able to have
our own lab, we have so much more data and that has
been so empowering.
